Training activity information
Details
Gain informed consent from an individual with azoospermia for extended genetic screening
Type
Developmental training activity (DTA)
Evidence requirements
Evidence the activity has been undertaken by the trainee​.
Reflection on the activity at one or more time points after the event including learning from the activity and/or areas of the trainees practice for development.
An action plan to implement learning and/or to address skills or knowledge gaps identified.
Considerations
- Introductions and confirming patient identity
- Informed consent process
- Communication of complex information to non-experts
- Two-way communication to ensure patient awareness of procedures
- Access to counselling services and support groups
- The role of clinical genetics
- PGT treatment options
Reflective practice guidance
The guidance below is provided to support reflection at different time points, providing you with questions to aid you to reflect for this training activity. They are provided for guidance and should not be considered as a mandatory checklist. Trainees should not be expected to provide answers to each of the guidance questions listed.
Before action
- What are the relevant extended genetic screening options for individuals with azoospermia?
- What are the key aspects of informed consent in the context of extended genetic screening for azoospermia?
- What information about the screening process and potential outcomes do you need to understand before the discussion?
- How will you document the consenting process?
- What insights do you hope to gain in explaining complex genetic information and the implications of screening to an individual facing azoospermia?
- What do you already know about informed consent procedures and genetic screening options?
- What challenges might arise in explaining the rationale and potential outcomes of extended genetic screening?
- How will you ensure the individual fully understands and consents?
- How do you feel about discussing potentially difficult medical information?
In action
- Focus on how you are explaining the purpose and implications of extended genetic screening to the individual with azoospermia. What information are you prioritising, and why?
- What decisions are you making regarding the level of detail and the language used to ensure the individual understands the information?
- What aspects of explaining complex genetic information feel straightforward, and what requires more careful articulation to avoid misunderstanding?
- How effective is your explanation in ensuring the individual can make an informed decision about extended genetic screening? How are you gauging their understanding?
- What challenges are you encountering in communicating this complex information clearly and sensitively?
- What are you learning about explaining genetic concepts and obtaining informed consent in this specific context?
- How does this discussion relate to your knowledge of genetics, male infertility, and ethical considerations in healthcare?
- If the individual expresses confusion or has specific questions, how are you adjusting your explanation to address their concerns?
- What support or resources might you need if you struggle to explain a particular aspect of the screening or its implications?
- Are you ensuring that the consent process is conducted ethically and in accordance with relevant guidelines?
On action
- What information did you provide to the individual about the purpose and nature of extended genetic screening?
- What were the individual’s initial reactions, questions, or concerns?
- How did you ensure the individual understood the potential implications of the screening results?
- What steps did you take to ensure the consent was freely given and informed?
- How effective were you in explaining complex genetic information in an accessible way?
- What are the key considerations when seeking informed consent for extended genetic screening in the context of azoospermia?
- Were there any aspects of the process that were challenging or that you felt could have been handled differently?
- How does obtaining informed consent align with best practice guidance and regulations?
- Are there any specific aspects of extended genetic screening or the implications of results that you need to understand better to explain them clearly?
- How will you adapt your approach to gaining informed consent in future similar situations?
- What resources (e.g., information leaflets, guidelines on consent) would be helpful for future practice?
Beyond action
- Have you revisited the experience of gaining informed consent for extended genetic screening in azoospermia?
- Have you encountered similar situations requiring informed consent for genetic testing?
- Has your understanding of the implications of genetic screening results evolved since this training activity?
- Have you discussed the complexities of informed consent in genetic testing with colleagues?
- How has this experience impacted your current practice in communication and partnership with the multidisciplinary team?
- Has this training activity influenced your approach to explaining complex genetic information to patients?
- How has it informed your understanding of when to involve and collaborate with the multidisciplinary team in such cases?
- What did you learn about the process of informed consent and communicating genetic risks that will be relevant in future patient interactions?
- How has this experience shaped your awareness of ethical and legal considerations in genetic testing?
Relevant learning outcomes
| # | Outcome |
|---|---|
| # 2 |
Outcome
Evaluate the risk of transmissible and heritable conditions affecting offspring and partner/sperm recipients. |
| # 7 |
Outcome
Apply and adapt skills to communicate effectively with patients and the multidisciplinary team. |
| # 8 |
Outcome
Practice in partnership with the multidisciplinary team and other clinical specialties in the investigation and management of patients referred to andrology services. |